Deutsche Bank’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-238,918
| Closed | -$9.18M | – | 3915 |
|
|
2023
Q2 | $9.18M | Buy |
238,918
+185,078
| +344% | +$4.75M | ﹤0.01% | 1013 |
|
|
2023
Q1 | $1.25M | Buy |
53,840
+31,610
| +142% | +$753K | ﹤0.01% | 1965 |
|
|
2022
Q4 | $582K | Buy |
22,230
+1,343
| +6% | +$29.8K | ﹤0.01% | 2360 |
|
|
2022
Q3 | $411K | Buy |
20,887
+235
| +1% | +$4.71K | ﹤0.01% | 2487 |
|
|
2022
Q2 | $361K | Sell |
20,652
-606
| -3% | -$9.51K | ﹤0.01% | 2792 |
|
|
2022
Q1 | $348K | Sell |
21,258
-2,488
| -10% | -$33.8K | ﹤0.01% | 2955 |
|
|
2021
Q4 | $387K | Buy |
23,746
+4,702
| +25% | +$66.9K | ﹤0.01% | 2994 |
|
|
2021
Q3 | $243K | Buy |
19,044
+373
| +2% | +$4.91K | ﹤0.01% | 3465 |
|
|
2021
Q2 | $264K | Buy |
18,671
+9,711
| +108% | +$155K | ﹤0.01% | 3624 |
|
|
2021
Q1 | $140K | Sell |
8,960
-842
| -9% | -$13.7K | ﹤0.01% | 3807 |
|
|
2020
Q4 | $155K | Buy |
9,802
+2,688
| +38% | +$40.6K | ﹤0.01% | 3614 |
|
|
2020
Q3 | $86K | Buy |
7,114
+644
| +10% | +$8.63K | ﹤0.01% | 3624 |
|
|
2020
Q2 | $75K | Buy |
6,470
+2,031
| +46% | +$28K | ﹤0.01% | 3605 |
|
|
2020
Q1 | $61K | Sell |
4,439
-10,160
| -70% | -$120K | ﹤0.01% | 3456 |
|
|
2019
Q4 | $85K | Sell |
14,599
-993
| -6% | -$5.4K | ﹤0.01% | 3661 |
|
|
2019
Q3 | $81K | Buy |
15,592
+4,931
| +46% | +$32.7K | ﹤0.01% | 3672 |
|
|
2019
Q2 | $79K | Sell |
10,661
-21,948
| -67% | -$334K | ﹤0.01% | 4323 |
|
|
2019
Q1 | $647K | Buy |
32,609
+17,434
| +115% | +$304K | ﹤0.01% | 3287 |
|
|
2018
Q4 | $199K | Sell |
15,175
-16,332
| -52% | -$326K | ﹤0.01% | 3878 |
|
|
2018
Q3 | $1.16M | Sell |
31,507
-61,160
| -66% | -$1.96M | ﹤0.01% | 3218 |
|
|
2018
Q2 | $3.24M | Sell |
92,667
-29,100
| -24% | -$1.12M | ﹤0.01% | 2625 |
|
|
2018
Q1 | $5.66M | Sell |
121,767
-10,086
| -8% | -$369K | ﹤0.01% | 2109 |
|
|
2017
Q4 | $4.94M | Sell |
131,853
-7,903
| -6% | -$345K | ﹤0.01% | 2037 |
|
|
2017
Q3 | $7.44M | Buy |
139,756
+41,181
| +42% | +$2.45M | 0.01% | 1653 |
|
|
2017
Q2 | $5.62M | Buy |
98,575
+35,670
| +57% | +$1.79M | ﹤0.01% | 1842 |
|
|
2017
Q1 | $3.38M | Sell |
62,905
-2,228
| -3% | -$126K | ﹤0.01% | 1915 |
|
|
2016
Q4 | $3.71M | Sell |
65,133
-207
| -0.3% | -$12.5K | ﹤0.01% | 1848 |
|
|
2016
Q3 | $4.06M | Buy |
65,340
+540
| +0.8% | +$38.2K | ﹤0.01% | 1881 |
|
|
2016
Q2 | $3.66M | Buy |
64,800
+6,850
| +12% | +$416K | ﹤0.01% | 1984 |
|
|
2016
Q1 | $3.71M | Buy |
57,950
+27,342
| +89% | +$2.21M | ﹤0.01% | 1952 |
|
|
2015
Q4 | $4.3M | Buy |
30,608
+23,206
| +314% | +$3.15M | ﹤0.01% | 1895 |
|
|
2015
Q3 | $716K | Sell |
7,402
-499
| -6% | -$59.4K | ﹤0.01% | 3144 |
|
|
2015
Q2 | $1.2M | Buy |
+7,901
| New | +$1.3M | ﹤0.01% | 2848 |
|
Deutsche Bank's KDNY Position: Q3 2023 in Review
Deutsche Bank sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 238,918 shares — an estimated $9.18M sold.
Deutsche Bank first reported a position in KDNY in Q2 2015 and held it in 33 quarters. The position peaked at $9.18M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Deutsche Bank reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Deutsche Bank sold 238,918 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9.18M.
- Deutsche Bank first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 33 quarters.
- Deutsche Bank's Chinook Therapeutics, Inc. Common Stock position peaked at $9.18M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.